Literature DB >> 1149789

Liver blood flow and blood volume following chronic phenobarbitone administration.

E E Ohnhaus, J T Locher.   

Abstract

Mlae rats were ra&ndomly divided into 2 groups one of which received 30 mg/kh phenobarbitone for 4 days i.p. and the other sodium chloride. Liver blood flow was measured 24 hr following the last injection of phenobarbitone or sodium chloride using the radioactive colloidal gold clearance technique. In addition, blood volume, liver weight and extraction of radioactive gold were estimated. Following 4 daily infections of phenobarbitone the body weight and the blood volume of both groups were not significantly different. The liver weight in the phenobarbitone treated groups was 27% higher than that found in the control group. Liver blood flow increased from 22.7 ml/min (92,8 ml/min/kg body weight) to 30.1 ml/min (123.7 ml/min/kg body weight). This increase of 33% was highly significant (p less than 0.005). In contrast, the extraction of radioactive gold was 11% lower in the phenobarbitone treated groups than in the controls. The earlier, semiquanititative finding of increased blood flow using a chronic implanted thermocouple could thus be quantified by the present study.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1149789     DOI: 10.1016/0014-2999(75)90036-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

Review 1.  Altered hepatic blood flow and drug disposition.

Authors:  A S Nies; D G Shand; G R Wilkinson
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

2.  Age-related changes in liver size and hepatic blood flow. The influence on drug metabolism in the elderly.

Authors:  K W Woodhouse; H A Wynne
Journal:  Clin Pharmacokinet       Date:  1988-11       Impact factor: 6.447

Review 3.  Role of the lung in total body clearance of circulating drugs.

Authors:  R A Roth; D A Wiersma
Journal:  Clin Pharmacokinet       Date:  1979 Sep-Oct       Impact factor: 6.447

4.  Methods of the assessment of the effect of drugs on liver blood flow in man.

Authors:  E E Ohnhaus
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335

5.  Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants.

Authors:  H I Pirttiaho; E A Sotaniemi; R O Pelkonen; U Pitkänen
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

6.  Comparison of the effects of the hypolipidaemic agents ICI53072 and clofibrate with those of phenobarbitone on liver size, blood flow and DNA content in the rat.

Authors:  J S Berman; C R Hiley; A C Wilson
Journal:  Br J Pharmacol       Date:  1983-03       Impact factor: 8.739

7.  Intra-arterial administration of hexobarbital enantiomers to the rat: disposition and estimation of apparent extraction ratio.

Authors:  M Van der Graaff; N P Vermeulen; D D Breimer
Journal:  Pharm Weekbl Sci       Date:  1986-04-25

8.  Effect of polybrominated biphenyls on hepatic excretory function in rats and mice.

Authors:  S Z Cagen; J E Gibson
Journal:  Environ Health Perspect       Date:  1978-04       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.